David Sinclair· PhD
One way though, would be to use some of these adversity mimetics to get that epigenome to reset.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
One way though, would be to use some of these adversity mimetics to get that epigenome to reset.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
That's what some researchers have done in mice, at least, in a fairly recent study, actually this year, using a combination compound. Including cyclosporine, a minoxidil, which is the cream that we talked about earlier, and then another pigment-promoting drug. Turns out it's called tacrolimus, which is a very similar molecule to rapamycin or also known as sirolimus